We have also shown that endogenous antioxidant defense mechanisms were dysregulated in ARC patients with hypertension, as plasma GPx was upregulated, while the other antioxidants, including total thiol groups, SOD and FRAP, were significantly reduced. This evidence concerns the gene SOD1 and hypertensive disorder.